Applied StemCell, Inc., a global provider of gene editing and stem cell-based services, as well as a leader in molecular and cellular reference standard products for clinical diagnostics markets, is proud to receive certifications for two International Organization for Standardization (ISO) Quality Management Systems (QMS) on October 20, 2017, the ISO 9001:2015 and 13485:2016. The […]
SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease. The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers. Viscient is targeting early discovery […]
SHANGHAI, China and CUPERTINO, Calif. — Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and effective stem cell therapies for degenerative diseases, today announced the establishment of a strategic partnership with Thermo Fisher Scientific (China) Ltd. (Thermo Fisher) to build a […]
Fluicell AB is extremely pleased to announce the signing of a license agreement with Cellectricon AB, granting the exclusive right, inter alia , to sell the Dynaflow Resolve technology worldwide and to use the related IP rights. The Dynaflow Resolve system is considered by many, to be the premier secondary ion channel screening platform on the market, […]
Key appointments follow on Series A financing to support the commercialization and distribution of the world’s first precision genomics platform for high throughput single-cell DNA analysis SOUTH SAN FRANCISCO, Calif.—Mission Bio, Inc., a leader in single-cell analysis and precision genomics, today announced new additions to the senior management team as the company scales and commercializes […]
The Translational Research Institute (TRI), Brisbane has become the first centre in Australia and the Asia Pacific region to adopt the Livecyte™ Cell Imaging and Analysis system. TRI was formed to enhance collaboration between science, healthcare and industry with the purpose of accelerating the application of innovative scientific research to improve healthcare outcomes. The Institute, […]
Feeling limited and underwhelmed by your flow cytometer automation? Stratedigm’s all new Open API gives you the freedom you deserve and the future-proof growth you need. There are many components that can be apart of an automation system like shakers, liquid handlers, incubators, storage, schedulers, and analyzers. And with Stratedigm’s Open API, you can expand […]
Avalon Forms Subsidiary U.S. Company, GenExosome Technologies Inc., for the Global Advancement of Exosome Technology for Diagnosis and Treatment of Diseases FREEHOLD, NJ — Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that its majority-owned subsidiary GenExosome Technologies Inc. (GenExosome) acquired 100% of the outstanding capital stock of Beijing Jieteng (Beijing GenExosome) […]
Call to unite stakeholders and experts Leuven – The world-leading research and innovation hub in nano-electronics and digital technologies imec announced today that is has joined ORCHID, a European initiative that will establish a European infrastructure to enable coordinated development, production and implementation of Organs-on-Chips by a consortium of academic and private partners. In total six […]
Charles River to license PDX lines to InSphero for development of 3D InSight™ PDX Microtissues, expansion of in vitro oncology services. PDF Version Schlieren, Switzerland InSphero AG and Charles River Laboratories International, Inc. today announced a partnership through which Charles River will license its collection of patient-derived xenograft (PDX) tumors to InSphero. Additionally, Charles River will leverage InSphero’s […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
